CIPLA LETROZOLE letrozole 2.5mg film-coated tablet blister pack

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

letrozole, Quantity: 2.5 mg

Mevcut itibaren:

Cipla Australia Pty Ltd

INN (International Adı):

Letrozole

Farmasötik formu:

Tablet, film coated

Kompozisyon:

Excipient Ingredients: lactose monohydrate; sodium starch glycollate; microcrystalline cellulose; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 400

Uygulama yolu:

Oral

Paketteki üniteler:

10, 30

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

For the treatment of postmenopausal women with hormone receptor positive breast cancer (see Clinical Trials). The safety and efficacy of neoadjuvant use of letrozole has not been established. Letrozole is not indicated in hormone receptor negative disease.

Ürün özeti:

Visual Identification: Yellow circular, biconvex, film coated tablet debossed with LT on one side and 2.5 on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2016-06-01